Kevin McKernan
@Kevin_McKernan
Cannabis Genome Project,2011. SOLiD sequencer. R&D lead Human Genome Project at MIT/WIBR. Founder- Medicinal Genomics.
Joined April 2009
3.4K Following 121.8K Followers
It’s a bit ironic that the cheapest form of qPCR (SYBR green) shows this 16-32 fold variance in amplicon size alone.
Add in the RNA:DN/ hybrids and the qPCR the regulators are using could vary 1000 fold.
That’s exactly what Pharma wants.
An adjuvant you can modulate a 1000 fold and the FDA is too stupid to know it’s happening.
Show more
